Toll Free: 1-888-928-9744

Asia-Pacific Prostate Cancer Drugs Industry 2018 Market Research Report

Published: Feb 13, 2018 | Pages: 129 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the Asia-Pacific Prostate Cancer Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Prostate Cancer Drugs for these regions, from 2013 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Prostate Cancer Drugs market competition by top manufacturers/players, with Prostate Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie
    Astellas Pharma
    Astra Zeneca
    Johnson & Johnson
    Sanofi
    GlaxoSmithKline
    Merck Group
    Novartis
    Amgen
    Bayer HealthCare
    Ferring Pharmaceutical
    Janssen Pharmaceuticals
    Endo Pharmaceuticals
    BMS
    Takeda Pharmaceuticals
    Northwest Biotherapeutics
    Teva Pharmaceutical
    Boehringer Ingelheim
    Foresee Pharmaceuticals
    Tokai Pharmaceuticals
    Spectrum Pharmaceuticals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Hormonal Therapy
    Chemotherapy
    Immunotherapy
    Targeted Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinics
    Hospitals
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Asia-Pacific Prostate Cancer Drugs Market Report 2018
1 Prostate Cancer Drugs Overview
    1.1 Product Overview and Scope of Prostate Cancer Drugs
    1.2 Classification of Prostate Cancer Drugs by Product Category
        1.2.1 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Comparison by Types (2013-2025)
        1.2.2 Asia-Pacific Prostate Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Hormonal Therapy
        1.2.4 Chemotherapy
        1.2.5 Immunotherapy
        1.2.6 Targeted Therapy
    1.3 Asia-Pacific Prostate Cancer Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Prostate Cancer Drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025)
        1.3.2 Clinics
        1.3.3 Hospitals
        1.3.4 Other
    1.4 Asia-Pacific Prostate Cancer Drugs Market by Region
        1.4.1 Asia-Pacific Prostate Cancer Drugs Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 China Status and Prospect (2013-2025)
        1.4.3 Japan Status and Prospect (2013-2025)
        1.4.4 South Korea Status and Prospect (2013-2025)
        1.4.5 Taiwan Status and Prospect (2013-2025)
        1.4.6 India Status and Prospect (2013-2025)
        1.4.7 Southeast Asia Status and Prospect (2013-2025)
        1.4.8 Australia Status and Prospect (2013-2025)
    1.5 Asia-Pacific Market Size (Value and Volume) of Prostate Cancer Drugs (2013-2025)
        1.5.1 Asia-Pacific Prostate Cancer Drugs Sales and Growth Rate (2013-2025)
        1.5.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate (2013-2025)

2 Asia-Pacific Prostate Cancer Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Prostate Cancer Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2013-2018)
        2.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Type (2013-2018)
    2.3 Asia-Pacific Prostate Cancer Drugs (Volume) by Application
    2.4 Asia-Pacific Prostate Cancer Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Region (2013-2018)
        2.4.2 Asia-Pacific Prostate Cancer Drugs Revenue and Market Share by Region (2013-2018)

3 China Prostate Cancer Drugs (Volume, Value and Sales Price)
    3.1 China Prostate Cancer Drugs Sales and Value (2013-2018)
        3.1.1 China Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        3.1.2 China Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        3.1.3 China Prostate Cancer Drugs Sales Price Trend (2013-2018)
    3.2 China Prostate Cancer Drugs Sales Volume and Market Share by Type
    3.3 China Prostate Cancer Drugs Sales Volume and Market Share by Application

4 Japan Prostate Cancer Drugs (Volume, Value and Sales Price)
    4.1 Japan Prostate Cancer Drugs Sales and Value (2013-2018)
        4.1.1 Japan Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        4.1.2 Japan Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        4.1.3 Japan Prostate Cancer Drugs Sales Price Trend (2013-2018)
    4.2 Japan Prostate Cancer Drugs Sales Volume and Market Share by Type
    4.3 Japan Prostate Cancer Drugs Sales Volume and Market Share by Application

5 South Korea Prostate Cancer Drugs (Volume, Value and Sales Price)
    5.1 South Korea Prostate Cancer Drugs Sales and Value (2013-2018)
        5.1.1 South Korea Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        5.1.2 South Korea Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        5.1.3 South Korea Prostate Cancer Drugs Sales Price Trend (2013-2018)
    5.2 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Type
    5.3 South Korea Prostate Cancer Drugs Sales Volume and Market Share by Application

6 Taiwan Prostate Cancer Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Prostate Cancer Drugs Sales and Value (2013-2018)
        6.1.1 Taiwan Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        6.1.2 Taiwan Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        6.1.3 Taiwan Prostate Cancer Drugs Sales Price Trend (2013-2018)
    6.2 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Prostate Cancer Drugs Sales Volume and Market Share by Application

7 India Prostate Cancer Drugs (Volume, Value and Sales Price)
    7.1 India Prostate Cancer Drugs Sales and Value (2013-2018)
        7.1.1 India Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        7.1.2 India Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        7.1.3 India Prostate Cancer Drugs Sales Price Trend (2013-2018)
    7.2 India Prostate Cancer Drugs Sales Volume and Market Share by Type
    7.3 India Prostate Cancer Drugs Sales Volume and Market Share by Application

8 Southeast Asia Prostate Cancer Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Prostate Cancer Drugs Sales and Value (2013-2018)
        8.1.1 Southeast Asia Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        8.1.2 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        8.1.3 Southeast Asia Prostate Cancer Drugs Sales Price Trend (2013-2018)
    8.2 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Application

9 Australia Prostate Cancer Drugs (Volume, Value and Sales Price)
    9.1 Australia Prostate Cancer Drugs Sales and Value (2013-2018)
        9.1.1 Australia Prostate Cancer Drugs Sales Volume and Growth Rate (2013-2018)
        9.1.2 Australia Prostate Cancer Drugs Revenue and Growth Rate (2013-2018)
        9.1.3 Australia Prostate Cancer Drugs Sales Price Trend (2013-2018)
    9.2 Australia Prostate Cancer Drugs Sales Volume and Market Share by Type
    9.3 Australia Prostate Cancer Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Prostate Cancer Drugs Players/Suppliers Profiles and Sales Data
    10.1 AbbVie
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.1.4 Main Business/Business Overview
    10.2 Astellas Pharma
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.2.4 Main Business/Business Overview
    10.3 Astra Zeneca
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.3.4 Main Business/Business Overview
    10.4 Johnson & Johnson
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.4.4 Main Business/Business Overview
    10.5 Sanofi
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.5.4 Main Business/Business Overview
    10.6 GlaxoSmithKline
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.6.4 Main Business/Business Overview
    10.7 Merck Group
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.7.4 Main Business/Business Overview
    10.8 Novartis
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.8.4 Main Business/Business Overview
    10.9 Amgen
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.9.4 Main Business/Business Overview
    10.10 Bayer HealthCare
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Prostate Cancer Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        10.10.4 Main Business/Business Overview
    10.11 Ferring Pharmaceutical
    10.12 Janssen Pharmaceuticals
    10.13 Endo Pharmaceuticals
    10.14 BMS
    10.15 Takeda Pharmaceuticals
    10.16 Northwest Biotherapeutics
    10.17 Teva Pharmaceutical
    10.18 Boehringer Ingelheim
    10.19 Foresee Pharmaceuticals
    10.20 Tokai Pharmaceuticals
    10.21 Spectrum Pharmaceuticals

11 Prostate Cancer Drugs Manufacturing Cost Analysis
    11.1 Prostate Cancer Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Prostate Cancer Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Prostate Cancer Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Prostate Cancer Drugs Market Forecast (2018-2025)
    15.1 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
        15.1.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast (2018-2025)
        15.1.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast (2018-2025)
        15.1.3 Asia-Pacific Prostate Cancer Drugs Price and Trend Forecast (2018-2025)
    15.2 Asia-Pacific Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
        15.2.1 Asia-Pacific Prostate Cancer Drugs Sales Volume and Growth Rate Forecast by Region (2018-2025)
        15.2.2 Asia-Pacific Prostate Cancer Drugs Revenue and Growth Rate Forecast by Region (2018-2025)
        15.2.3 China Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.4 Japan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.5 South Korea Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.6 Taiwan Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.7 India Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.8 Southeast Asia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.9 Australia Prostate Cancer Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
    15.3 Asia-Pacific Prostate Cancer Drugs Sales, Revenue and Price Forecast by Type (2018-2025)
        15.3.1 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Type (2018-2025)
        15.3.2 Asia-Pacific Prostate Cancer Drugs Revenue Forecast by Type (2018-2025)
        15.3.3 Asia-Pacific Prostate Cancer Drugs Price Forecast by Type (2018-2025)
    15.4 Asia-Pacific Prostate Cancer Drugs Sales Forecast by Application (2018-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Prostate Cancer Drugs
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2017
    Figure Hormonal Therapy Product Picture
    Figure Chemotherapy Product Picture
    Figure Immunotherapy Product Picture
    Figure Targeted Therapy Product Picture
    Figure Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) by Application (2013-2025)
    Figure Asia-Pacific Sales Market Share of Prostate Cancer Drugs by Application in 2017
    Figure Clinics Examples
    Table Key Downstream Customer in Clinics
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Asia-Pacific Prostate Cancer Drugs Market Size (Million USD) by Region (2013-2025)
    Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate (2013-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Sales Volume (K Pcs)(2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Prostate Cancer Drugs Sales Share by Players/Suppliers
    Figure Asia-Pacific Prostate Cancer Drugs Market Major Players Product Revenue (Million USD) 2013-2018
    Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players
    Figure 2017 Asia-Pacific Prostate Cancer Drugs Revenue Share by Players
    Table Asia-Pacific Prostate Cancer Drugs Sales and Market Share by Type (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales Share by Type (2013-2018)
    Figure Sales Market Share of Prostate Cancer Drugs by Type (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Growth Rate by Type (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Prostate Cancer Drugs by Type (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue Growth Rate by Type (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Region (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales Share by Region (2013-2018)
    Figure Sales Market Share of Prostate Cancer Drugs by Region (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region in 2017
    Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Prostate Cancer Drugs by Region (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Region in 2017
    Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Application (2013-2018)
    Table Asia-Pacific Prostate Cancer Drugs Sales Share (%) by Application (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2013-2018)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2013-2018)
    Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table China Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure China Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table China Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure China Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table Japan Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table Japan Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure South Korea Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table South Korea Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table South Korea Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure South Korea Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Taiwan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table Taiwan Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Taiwan Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table India Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure India Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2013-2018)
    Table India Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure India Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Australia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2013-2018)
    Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2013-2018)
    Table Australia Prostate Cancer Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Type in 2017
    Table Australia Prostate Cancer Drugs Sales Volume (K Pcs) by Applications (2013-2018)
    Table Australia Prostate Cancer Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Australia Prostate Cancer Drugs Sales Volume Market Share by Application in 2017
    Table AbbVie Prostate Cancer Drugs Basic Information List
    Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure AbbVie Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure AbbVie Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure AbbVie Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Astellas Pharma Prostate Cancer Drugs Basic Information List
    Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Astellas Pharma Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Astellas Pharma Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Astra Zeneca Prostate Cancer Drugs Basic Information List
    Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Astra Zeneca Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Astra Zeneca Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Johnson & Johnson Prostate Cancer Drugs Basic Information List
    Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Johnson & Johnson Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Sanofi Prostate Cancer Drugs Basic Information List
    Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Sanofi Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Sanofi Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Sanofi Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table GlaxoSmithKline Prostate Cancer Drugs Basic Information List
    Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure GlaxoSmithKline Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Merck Group Prostate Cancer Drugs Basic Information List
    Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Merck Group Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Merck Group Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Merck Group Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Novartis Prostate Cancer Drugs Basic Information List
    Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Novartis Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Novartis Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Novartis Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Amgen Prostate Cancer Drugs Basic Information List
    Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Amgen Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Amgen Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Amgen Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Bayer HealthCare Prostate Cancer Drugs Basic Information List
    Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Bayer HealthCare Prostate Cancer Drugs Sales Market Share in Asia-Pacific (2013-2018)
    Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share in Asia-Pacific (2013-2018)
    Table Ferring Pharmaceutical Prostate Cancer Drugs Basic Information List
    Table Janssen Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table Endo Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table BMS Prostate Cancer Drugs Basic Information List
    Table Takeda Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table Northwest Biotherapeutics Prostate Cancer Drugs Basic Information List
    Table Teva Pharmaceutical Prostate Cancer Drugs Basic Information List
    Table Boehringer Ingelheim Prostate Cancer Drugs Basic Information List
    Table Foresee Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table Tokai Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table Spectrum Pharmaceuticals Prostate Cancer Drugs Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price (USD/Pcs) Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Prostate Cancer Drugs
    Figure Manufacturing Process Analysis of Prostate Cancer Drugs
    Figure Prostate Cancer Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017
    Table Major Buyers of Prostate Cancer Drugs
    Table Distributors/Traders List
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) and Trend Forecast (2018-2025)
    Table Asia-Pacific Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Volume Market Share Forecast by Region in 2025
    Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Region (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Region in 2025
    Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure South Korea Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure South Korea Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Taiwan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Taiwan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Australia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Australia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Type (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Type (2018-2025)
    Table Asia-Pacific Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Revenue Market Share Forecast by Type (2018-2025)
    Table Asia-Pacific Prostate Cancer Drugs Price (USD/Pcs) Forecast by Type (2018-2025)
    Table Asia-Pacific Prostate Cancer Drugs Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Asia-Pacific Prostate Cancer Drugs Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...

To learn more about this report, request a free sample copy

Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify